Bomhard Ernst M
1 REACh ChemConsult GmbH, Dresden, Germany.
Toxicol Pathol. 2017 Apr;45(3):389-401. doi: 10.1177/0192623316688959. Epub 2017 Jan 31.
This review analyzes the published data on cases of pulmonary alveolar proteinosis (PAP) in workers inhaling crystalline aluminum, indium, silicon, and titanium particles and possible sequelae, that is, inflammation and fibrosis, and compares these findings with those from animal experiments. In inhalation studies in rodents using crystalline indium and gallium compounds, pronounced PAP followed by inflammation and fibrosis down to very low concentration ranges have been reported. Crystalline aluminum, silicon, and titanium compounds also induced comparable pulmonary changes in animals, though at higher exposure levels. Laboratory animal species appear to react to the induction of PAP with varying degrees of sensitivity. The sensitivity of humans to environmental causes of PAP seems to be relatively low. Up to now, no cases of PAP, or other pulmonary diseases in humans, have been described for gallium compounds. However, a hazard potential can be assumed based on the results of animal studies. Specific particle properties, responsible for the induction of PAP and its sequelae, have not been identified. This review provides indications that, both in animal studies and in humans, PAP is not often recognized due to the absence of properly directed investigation or is concealed behind other forms of lung pathology.
本综述分析了已发表的关于吸入结晶铝、铟、硅和钛颗粒的工人发生肺泡蛋白沉积症(PAP)病例及其可能的后遗症(即炎症和纤维化)的数据,并将这些结果与动物实验结果进行了比较。在使用结晶铟和镓化合物对啮齿动物进行的吸入研究中,已报告在极低浓度范围内会出现明显的PAP,随后出现炎症和纤维化。结晶铝、硅和钛化合物在动物中也会引起类似的肺部变化,不过暴露水平更高。实验动物物种对PAP诱导的反应似乎具有不同程度的敏感性。人类对PAP环境病因的敏感性似乎相对较低。到目前为止,尚未描述镓化合物导致人类发生PAP或其他肺部疾病的病例。然而,根据动物研究结果可以推断存在潜在危害。尚未确定导致PAP及其后遗症的特定颗粒特性。本综述表明,在动物研究和人类研究中,由于缺乏针对性的调查,PAP往往未被识别,或者被掩盖在其他形式的肺部病理学背后。